Summary
A series of forty 5′-ester derivatives of 5-ethyl-2′-deoxyuridine (EDU) have been evaluated for their inhibitory effects on the growth and metabolism of murine leukemia L1210 cells. Several EDU esters proved as potent as EDU in their inhibitory effects on L1210 cell growth (inhibitory dose-50: 5–10 μg/ml), suggesting that these esters were readily hydrolyzed to release the parent compound EDU. That the EDU esters had to be hydrolyzed first to EDU was further suggested by the dependence of their antiproliferative action on the thymidine kinase activity of the cells. It was further ascertained that EDU and its esters acquired their antiproliferative effects by an interaction with dCTP biosynthesis, possibly at the CDP ribonucleotide reductase step. Under conditions where thymidine was readily incorporated, we were unable to demonstrate any incorporation of EDU into L1210 cell DNA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goldin A, Sandberg JS, Henderson ES: The chemotherapy of human and animal acute leukemia. Cancer Chemother Rep 55:309–505, 1971
Danenberg PV: Thymidylate synthetase — a target enzyme in cancer chemotherapy. Biochim Biophys Acta 473:73–92, 1977
Ansfield FJ, Ramirez G: Phase I and II studies of 2t'-deoxy-5-(trifluoromethyl)-uridine (NCS-75520). Cancer Chemother Rep 55:205–208, 1971
Bobek M, Bloch A: The chemistry and biology of some new nucleoside analogs active against tumor cells. In: RE Harmon, RK Robins, LB Townsend (eds): Chemistry and Biology of Nucleosides and Nucleotides. Academic Press, New York, 1978, pp 135–148
Kalman TI, Bardos TJ: Enzymatic studies relating to the mode of action of 5-mercapto-2′-deoxyuridine. Mol Pharmacol 6:621–630, 1970
Langen P, Waschke SR, Waschke K, Bärwolff D, Reefschläger J, Schulz P, Preussel B, Lehmann C: 5-Formyl-2′-deoxyuridine: cytostatic and antiviral properties and possible modes of action. Acta Biol Med Germ 35:1625–1633, 1976
Washtien W, Matsuda A, Wataya Y, Santi DV: Cytotoxicity of 5-nitro-2′-deoxyuridine by in vivo inhibition of thymidylate synthetase. Biochem Pharmacol 27:2663–2666, 1978
Santi DV: Perspectives on the design and biochemical pharmacology of inhibitors of thymidylate synthetase. J Med Chem 23:103–111, 1980
Waschke S, Reefschläger J, Bärwolff D, Langen P: 5-Hydroxymethyl-2′-deoxyuridine, a normal DNA constituent in certain Bacillus subtilis phages is cytostatic for mammalian cells. Nature 255:629–630, 1975
Langen P, Bärwolff D: Cytostatic action of some C-5 modified 2′-deoxyuridine derivatives. Acta Biol Med Germ 34:K7-K10, 1975
Silagi S, Balint RF, Gauri KK: Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine. Cancer Res 37:3367–3373, 1977
Balzarini J, De Clercq E, Torrence PF, Merles MP, Park JS, Schmidt CL, Shugar D, Barr PJ, Jones AS, Verfielst G, Walker RT: Role of thymidine kinase in the inhibitory activity of 5-substituted-2′-deoxyuridines on the growth of human and murine tumor cell lines. Biochem Pharmacol 31:1089–1095, 1982
Balzarini J, De Clercq E: Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2′-deoxycytidines and cytosine arabinosides on tumor cell growth. Mol Pharmacol 23:175–181, 1983
Sowa T, Ouchi S: Diacyl synthesis of 5′-nucleotides by the selective phosphorylation of a primary hydroxyl group of nucleosides with phosphoryl chloride. Bull Chem Soc 48: 2084–2090, 1975
Verheyden JP, Moffat JG: Halo sugar nucleosides. II. Iodination of secondary hydroxyl groups of nucleosides with methyltriphenoxyphosphonium iodide. J Org Chem 35:2868–2878, 1970
Hunston RN, Jehangir M, Jones AS, Walker RT: Synthesis of 2′-deoxy-5-fluoro-5′-0–1′', 3′', 2′'-oxazophosphocyclohexa-2′'-yluridine 2′'-oxide and related compounds. Tetrahedron 36:2337–2340, 1980
Mundill PHC, Fries RW, Woenckhaus C, Plapp BV: Sulfonate analogues of adenosine nucleotides as inhibitors of nucleotide-binding enzymes. J Med Chem 24:474–477, 1981
Keppler K, Kiefer G, De Clercq E: In preparation, 1983
Fleming WC, Lee WW, Henry DW: Synthesis of nucleoside 5′-carbamates. J Med Chem 16:570–571, 1973
Unpublished results
Horwitz JP, Tomson AJ, Urbanski JA, Chua J: Nucleosides. I. 5′-Amino-5′-deoxyuridine and 5′-amino-5′-deoxythymidine. J Org Chem 27:3045–3048, 1962
Mungall WS, Lemmen LJ, Lemmen KL, Kaiser Dethmers J, Norling LL: Nucleoside 5′-monophosphate analogues. Synthesis of 5′-sulfamino-5′-deoxynucleosides. J Med Chem 21:704–706, 1978
De Clercq E, Balzarini J, Torrence PF, Mertes MP, Schmidt CL, Shugar D, Barr PJ, Jones AS, Verhelst G, Walker RT: Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2′-deoxyuridines on mouse leukemia L1210 cell growth. Mol Pharmacol 19:321–330, 1981
Balzarini J, De Clercq E, Mertes MP, Shugar D, Torrence PF: 5-Substituted 2′-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase. Biochem Pharmacol 31: 3673–3682, 1982
Momparler RL, Fischer GA: Mammalian deoxycytidine kinase. I. Deoxycytidine kinase: purification properties and kinetic studies with cytosine arabinoside. J Biol Chem 243: 4298–4303, 1968
Plagemann PGW, Marz R, Wohlhueter RM: Transport and metabolism of deoxycytidine and 1-β-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. Cancer Res 38:978–989, 1978
Fried J, Perez AG, Doblin JM, Clarkson BD: Cytotoxic and cytokinetic effects to thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture. Cancer Res 41:2627–2632, 1981
Ross DD, Akman SA, Schrecker AW, Bachur NR: Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools. Cancer Res 41:4493–4498, 1981
Kinahan JJ, Kowal EP, Grindey GB: Biochemical and antitumor effects of the combination of thymidine and 1-β-D-arabinofuranosylcytosine against leukemia L1210. Cancer Res 41:445–451, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Balzarini, J., De Clercq, E., Kiefer, G. et al. Antitumor cell and antimetabolic effects of 5-ethyl-2′-deoxyuridine and 5′-substituted 5-ethyl-2′-deoxyuridine derivatives. Invest New Drugs 2, 35–47 (1984). https://doi.org/10.1007/BF00173785
Issue Date:
DOI: https://doi.org/10.1007/BF00173785